March 2022

New study will examine the impact on paediatric haemophilia standard of care of the 2018 introduction of novel genetic therapies

In 2017, a study was undertaken to understand the burden of illness for paediatric haemophilia patients, treated with the standard of care available at the time. 785 patients were included in the study, which was conducted across Germany, France, Italy, Spain and the United Kingdom. The study, identified by the acronym CHESS PAEDS raised awareness of the prevalence of problem joints and associated quality of life impairment for these patients.
Read More
March 2022

HCD Economics is proud to be shortlisted for the High Sheriff of Cheshire Award for Excellence in Enterprise

The High Sheriff of Cheshire Awards for Enterprise are well established within our region and culminate in an important date in the business year. Now in their 15th year, the High Sheriff’s Awards for Enterprise were introduced in 2006 by the then High Sheriff of Cheshire, David Briggs, MBE KStJ. The awards recognise outstanding achievements by enterprises in Cheshire, Halton and Warrington. HCD Economics launched its innovative business model in 2016 from its Daresbury base at the Sci-Tech Innovation Centre, a science and business hub located just outside Warrington.
Read More
February 2022

An evidence based approach = health information, expertise and best practices easily accessible to policy makers and policy influencers

An evidence based approach = health information, expertise and best practices easily accessible to policy makers and policy influencers’ (adapted from a quote by Vytenis Andriukaitis (WHO Envoy for the European region and former EU Commissioner for Health and Food Safety). HCD Economics has demonstrated a commitment to the generation, analysis and advocacy communication of health information, expertise and best practices that informs and influences policy making. This includes work undertaken in and for the healthcare sector in the EU. Consequently, the company committed to investing in establishing formal EU based organisation alongside the existing UK based HQ.
Read More
February 2022

A remarkably simple and helpful piece of research

'A remarkably simple and helpful piece of research' Chris Mullin, Chief Economist, UK Department of Health and Social Care This quote was among a number of twitter postings that commented on the publication of the paper reporting work undertaken by Idaira Rodriguez Santana and collaborators from the Centre from Health Economics (CHE) at University of York.
Read More
November 2021

HCD Economics celebrates 70th ‘news’ article

When HCD Economics launched its new website, following an intensive corporate strategic review in 2018, the Director’s committed to a news section that would be informative and of value to website visitors. In November, the 70th article was published, joining its predecessors in building up a solid knowledge base reflecting the ethos and research focus of HCD Economics.
Read More
October 2021

New CHESS study seeks research partners– CHESS will, for the first time, inform enhanced longitudinal understanding of the burden of illness for patients with haemophilia

Results from the first CHESS study were published in July 2017 (O’Hara et al. Orphanet Journal of Rare Diseases (2017) 12:106). The study investigated the burden of illness (BOI) for haemophilia patients and has been instrumental as a source of health economic evidence in advocating for access for these patients to new genetic advances in treatment.
Read More
October 2021

‘Socioeconomic evidence – a human aspect that science alone lacks’

‘Socioeconomic evidence – a human aspect that science alone lacks’ Tara Kearns (Vice President and Co-Founder, PFIC* Advocacy and Resource Network) ‘research is absolutely where my passion lies, as I know this will create the most change!’ Melanie Karakaidos (Director of Global Advocacy and Outreach, PFIC* Advocacy and Resource Network)
Read More